Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies
Condition(s):Advanced Solid TumorLast Updated:September 21, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Advanced Solid TumorLast Updated:September 21, 2023Terminated
Condition(s):Advanced Solid MalignanciesLast Updated:January 17, 2024Active, not recruiting
Condition(s):Advanced Solid MalignanciesLast Updated:July 8, 2019Completed
Condition(s):Progressive Solid Malignancies; Refractory Solid Malignancies; CancerLast Updated:April 24, 2020Terminated
Condition(s):Malignant Solid TumourLast Updated:May 28, 2015Completed
Condition(s):Advanced Solid MalignanciesLast Updated:February 8, 2024Recruiting
Condition(s):Solid Malignancies; Metastatic Castrate-resistant Prostate CancerLast Updated:November 19, 2019Completed
Condition(s):Advanced Solid MalignanciesLast Updated:March 27, 2024Recruiting
Condition(s):Solid MalignanciesLast Updated:February 12, 2024Active, not recruiting
Condition(s):MalignanciesLast Updated:March 23, 2012Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.